Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
06/1998
06/03/1998CN1183290A Anticancer drug
06/03/1998CN1183287A Paste for treating spur
06/03/1998CN1183286A Exterior use medical ointment for treating foot disorder and its preparing process
06/03/1998CN1183285A Pill for treatment nephritis
06/03/1998CN1183283A 海泉多乳生高活性乳酸菌制品及其制备方法 Seaspray much raw milk products with high activity of lactic acid bacteria and its preparation method
06/03/1998CN1183282A Oral liquid for strengthening liver and preparaing process thereof
06/03/1998CN1183281A Ointment contg. low-molecular heparin and its preparing method
06/03/1998CN1183280A Method for extracting deproteinized calf blood extract
06/03/1998CA2191940A1 Surgical wound healing acceleration
06/02/1998US5760020 Lipid emulsion
06/02/1998US5760015 Cyclodextrin compounds and methods of making and use thereof
06/02/1998US5759856 Co-culture of immortalized cell which expresses a factor needed by another cell in the culture, interleukins
06/02/1998US5759793 Method for mammalian cell separation from a mixture of cell populations
06/02/1998US5759774 Method of detecting circulating antibody types using dried or lyophilized cells
06/02/1998US5759766 Skin disorders with allogenic cells
06/02/1998US5759764 Cryopreservation solution
06/02/1998US5759585 Plasmalogen compositions and their use in neurodegenerative diseases treatment
06/02/1998US5759584 Method for treating skin afflicted with blemishes or acne with a composition comprising distilled wool wax acids and at least one monoglycerol monocarboxylic acid monoester
06/02/1998US5759554 Immunostimulatory bacterial cell wall traction
06/02/1998US5759543 Application of a cell culture of a fusarium fungus strain producer for medical uses
06/02/1998US5759539 Oxidizing ethanol to acetate in the blood
06/02/1998US5759536 Use of fas ligand to supress T-lymphocyte-mediated immune responses
06/02/1998US5759534 Methods of treating disease using sertoli cells and allografts or xenografts
06/02/1998CA2012278C Mutant of microbacterium, a strain 851r, and a process for producing 851r nutrient solution by application of the strain
06/02/1998CA1339894C Fusion proteins with a eukaryotic ballast portion
05/1998
05/29/1998CA2222828A1 Method for assessing oxidative stress and its control in humans
05/28/1998WO1998022617A1 Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer
05/28/1998WO1998022605A1 Improved methods for transducing cells
05/28/1998WO1998022588A2 An improved method for the production and purification of adenoviral vectors
05/28/1998WO1998022540A1 Mineral pigment microparticles covered with a chitin layer
05/28/1998WO1998022508A2 Process for tumour cell depletion of cd34-positive cells
05/28/1998WO1998022158A2 Graft prosthesis, materials and methods
05/28/1998WO1998022150A1 Method and apparatus for inactivating contaminants in biological fluid
05/28/1998WO1998022143A1 Chimeric retrovirus/adenovirus system
05/28/1998WO1998022133A1 NOVEL FabD
05/28/1998WO1998022126A1 USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS
05/28/1998WO1998022119A1 Utilization of an egg-based preparation as an antidepressant
05/28/1998WO1998022083A1 Therapeutic and cosmetic compositions, their use and method for the preparation thereof
05/28/1998WO1998021984A1 Ubiquinone-containing, non-alcoholic beverage
05/28/1998WO1998021966A2 Nematicidal bacillus strain and metabolite and methods of use thereof
05/28/1998WO1998021944A1 Method for conversion of blood type
05/28/1998DE19648209A1 Verfahren zur Tumorzelldepletion CD34-positiver Zellen Method for Tumorzelldepletion CD34-positive cells
05/28/1998CA2275438A1 Improved methods for transducing cells
05/28/1998CA2272925A1 Method for conversion of blood type
05/28/1998CA2272121A1 Chimeric retrovirus/adenovirus system
05/28/1998CA2271769A1 Use of conotoxin peptides imi and mii as cardiovascular agents
05/27/1998EP0844005A1 Dry-heat viral inactivation under controlled moisture conditions
05/27/1998EP0844002A1 Use of activated hemicellulose for the induction of interleukin-12
05/27/1998EP0843731A1 Adenovirus vectors for gene therapy
05/27/1998EP0843565A1 Coarse spray delivery of functional biologic materials
05/27/1998EP0843557A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
05/27/1998CN1182792A Method for extracting, cultivating and propagating ancient marine organisms and products thereof
05/27/1998CN1182617A Medicine for curing epilepsy and preparation method thereof
05/27/1998CN1182611A Traditional Chinese powder medicine for hepatosis
05/27/1998CN1182609A Weikang capsule for curing gastric disease
05/27/1998CN1182603A Brain reinforcing ointment
05/27/1998CN1182594A Method for producing extracted powder by pearl nucleus-removing and technology and device thereof
05/27/1998CN1182593A Chondroitiln sulfate and extrating method
05/27/1998CN1038512C Productive method of medicine for improving growth of liver cell
05/27/1998CN1038476C Method for preparing pill of hyperosteogeny
05/26/1998US5756668 Hypermethylated in cancer polypeptide, HIC-1
05/26/1998US5756320 Culturing microorganisms belonging to the genus streptomyces; isolation; exhibit inhibitory action on interleukin-6
05/26/1998US5756310 Culture product
05/26/1998US5756097 Immunotherapeutic treatment of cancer
05/26/1998US5756088 Containing unsaturated fatty acid and biotin
05/26/1998US5755814 Dermal-epidermal in vitro test system
05/25/1998CA2215929A1 Novel lep
05/22/1998WO1998021354A1 Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses
05/22/1998WO1998021345A1 Hsv/aav hybrid amplicon vectors
05/22/1998WO1998021327A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences
05/22/1998WO1998021312A1 Human hepatocytes in three-dimensional support systems
05/22/1998WO1998020932A2 Conditioning for allogeneic stem cell transplantation
05/22/1998WO1998020907A1 TGFβ1-RESPONSIVE CELLS FROM BONE MARROW
05/22/1998WO1998020906A2 Treatment of diabetes with transcription factor gene
05/22/1998WO1998020884A1 Apoptosis inducers
05/22/1998WO1998020883A1 Use of pvp or povidone for reducing bowel distension
05/22/1998WO1998020734A1 Adjuvant for transcutaneous immunization
05/22/1998WO1998020731A1 Msc-megakaryocyte precursor composition and method of isolating mscs associated with isolated megakaryocytes by isolating megakaryocytes
05/22/1998CA2271777A1 Hsv/aav hybrid amplicon vectors
05/22/1998CA2271758A1 Msc-megakaryocyte precursor composition and method of isolating mscs associated with isolated megakaryocytes by isolating megakaryocytes
05/22/1998CA2271734A1 Tgf.beta.1-responsive cells from bone marrow
05/22/1998CA2271705A1 Apoptosis inducing agent
05/22/1998CA2271464A1 Conditioning for allogeneic stem cell transplantation
05/22/1998CA2271100A1 Treatment of diabetes with transcription factor gene
05/22/1998CA2270943A1 Use of pvp or povidone for reducing bowel distension
05/22/1998CA2268018A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences
05/21/1998CA2221077A1 Dry-heat viral inactivation under controlled moisture conditions
05/20/1998EP0842670A1 Biomedical materials
05/20/1998EP0842279A2 Helper viruses for preparing recombinant viral vectors
05/20/1998EP0842269A1 Mocarhagin, a cobra venom protease, and therapeutic uses thereof
05/20/1998EP0842268A2 Methods and compositions for identifying morphogen analogs
05/20/1998EP0842189A1 Early onset alzheimer's disease gene and gene products
05/20/1998EP0841950A1 Neuronal progenitor cells and uses thereof
05/20/1998EP0841943A1 Avirulent herpetic viruses useful as tumoricidal agents and vaccines
05/20/1998EP0841942A1 Method for industrially producing a japanese encephalitis vaccine, and resulting vaccine
05/20/1998EP0841940A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
05/20/1998EP0841935A1 Modulation of endothelial cell proliferation
05/20/1998EP0633027A4 Compound for the biological stimulation and correction of the phenotype of an organism and a process for producing the same.
05/20/1998EP0546076B1 Use of anti-ICAM antibodies in the manufacture of a medicament FOR TREATING ENDOTOXIN SHOCK
05/20/1998CN1182452A Osteoprotegerine